Pictured: Marc Ladanyi
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Wednesday, August 6, 2014

A newly discovered gene mutation appears to be the driving force behind a particularly aggressive form of embryonal rhabdomyosarcoma, a rare cancer of the skeletal muscle.

Pictured: Aisha Hasan
Slide Show
By Media Staff  |  Monday, December 2, 2013

The grant, which Dr. Hasan will use to develop novel immune therapies for two childhood cancers, was presented at Memorial Sloan Kettering and involved a special activity for pediatric patients.

Pictured: Paul Meyers
Feature
By Celia Gittelson, BA  |  Thursday, September 26, 2013

On the occasion of Childhood Cancer Awareness Month, pediatric oncologist Paul A. Meyers talks about the evolution of pediatric cancer research and treatment at Memorial Sloan Kettering.

Patient Story
By Memorial Sloan Kettering  |  Monday, February 20, 2012

When five-year-old CJ Postighone was diagnosed with a rare pediatric cancer called rhabdomyosarcoma, he came to Memorial Sloan Kettering to receive a combination of surgery, chemotherapy, and radiation therapy.

Pictured: Marc Ladanyi & Laetitia Borsu
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Wednesday, February 1, 2012

Memorial Sloan Kettering researchers have performed the first large-scale genetic analysis of several pediatric cancers, identifying mutations and potential targets for therapies to treat the cancers.

Center News

Stay Informed

Get the latest information about cancer care and research every month.